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ApoptosisThyroid autonomy is a frequent cause of thyrotoxicosis in regions with iodine deﬁciency. Epidemiological data
suggest that iodide may inﬂuence the course of pre-existing thyroid autonomy.
Making use of FRTL-5 cells stably expressing a constitutively activating TSH receptor mutation as an in vitro
model of thyroid autonomy, we investigated the impact of iodide on proliferation, function and changes in
global gene expression.
We demonstrate that iodine inhibits growth in TSHR WT and L629F mutant FRTL-5 cells and downregulates e.g.
protocadherin cluster (Pcdha1–13) and thyroid responsive element (Thrsp). In addition functional genes e.g.
iodotyrosine deiodinase (iyd) and oncogen junB are upregulated, while sodium-iodide-symporter (Nis) and thyroid
peroxidase (Tpo) are downregulated by iodide.
Iodide tunes down the biological activity of autonomous thyrocytes andmay thus be of therapeutic beneﬁt not only
to prevent the occurrence of somatic TSHR mutations, causing thyroid autonomy, but also to slow down the
development of clinically relevant disease.cine, Division of Endocrinology
03 Leipzig, Germany. Fax: +49
Führer).
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Thyroid autonomy is deﬁned as the TSH-independent function and
proliferation of thyroid follicles [4,24]. The most frequent cause of
thyroid autonomy are TSH receptor mutations, that cause a
constitutive activation of the cAMP cascade resulting in stimulation
of thyroid function and growth [11,20]. Thyroid autonomy is highly
prevalent in geographic regions with iodide deﬁciency and rarely
occurs in iodide-sufﬁcient regions [15].
The link between thyroid autonomy and iodine deﬁciency is not
ultimately clariﬁed on the molecular level, however thyroid hormone
synthesis requires H2O2 as a co-substrate, which very likely represents
an important source of reactive oxygen species (ROS). In vitro, an
increased mRNA expression of oxidative defense genes during iodine
deﬁciency has been shown in thyroids of rat and mice [17]. Increased
oxidative stress may lead to DNA damage and may promote
mutagenesis e.g. the occurrence of gain-of-function TSHR mutations.
The impact of iodine on the further evolution of clonal thyroid
autonomy to clinically relevant thyroid disease has not been studied
on the molecular level so far. Iodine plays an important role in the
regulation of thyroid growth and function. Supraphysiological doses
of iodide have long been known to cause a temporary inhibition of
thyroid hormone synthesis, a process termed the Wolff–Chaikoffeffect, which is still used pre-operatively as “plummering” in some
thyrotoxic patients. In addition, iodine excess has been shown to
inhibit cell growth, induce apoptosis and affect cell morphology [25].
Hypothetically, iodine exposure might also suppress proliferation of
autonomous thyrocytes thereby slowing the development of
autonomous growth and preventing hyperthyroidism. Early support
for such hypothesis comes from the Pescopagano survey of patients
with known thyroid autonomy. In this study, hyperthyroidism
occurred twice as frequent in the iodide deﬁcient vs. the iodide-
sufﬁcient patient group, suggesting that iodide deﬁciency may
indeed be a selection factor for the clinically relevant development
of thyroid autonomy [2].
In this paper we expand on previous studies by the group of
Ludgate et al. using an in vitro model of thyroid autonomy [3,11] and
investigate iodine-induced changes in the transcriptome as well as its
effects on regulation of cell growth and function in early stage thyroid
autonomy compared to normal thyroid cells.
2. Material and methods
2.1. Cell culture conditions
We have studied the SB5 sub-clone of FRTL-5 cells stably expressing
wild-type (WT) TSH receptor or 2 different gain-of-function TSHR
mutants, L629F and A623I, introduced by retroviral infection as
previously described [11]. FRTL-5 cells were maintained in a 2:1:1
mixture of DMEM (PAA Laboratories, Cölbe, Germany): Ham's F12 (PAA
Laboratories, Cölbe, Germany): MCDB104 (GIBCO Life Technologies,
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(GIBCO Life Technologies, Karlsruhe, Germany), 10 μg/ml insulin,
0.4 μg/ml hydrocortisone (Calbiochem, San Diego, CA, USA), 45 μg/
ml ascorbic acid (Sigma, Seelze, Germany), 5 μg/ml transferrin
(Calbiochem, San Diego, CA, USA) and 5 mU/ml bovine TSH (Sigma,
Seelze, Germany). Depending on the parameters analyzed, the cells
were cultured in serum-containing medium, supplemented with
TSH and varying concentrations of NaI (or NaCl) as indicated.
2.2. Direct cell counting
Cells were plated in complete (serum-containing) medium with or
without TSH (1 mU/ml) in various iodide concentrations (1–50 mM
NaI) in a density of 5×104 cells/well in 12-well plates. Cells were
trypsinized on days 3, 6, 8 and 10, resuspended in phosphate buffered
saline solution (PBS) and counted using a Neubauer counting chamber.
Results are expressed as total counts per well. To monitor unspeciﬁc
osmolaric effects of the salt solutions, sodium chloride was used in all
experiments equivalent to the highest NaI concentration.
2.3. Apoptosis
Apoptosis was determined by staining cells with Annexin V-Cy5
(Ex/Em=649 nm/670 nm). Annexin V is used to identify the
externalization of phosphatidylserine during the progression of
apoptosis and, therefore, is a marker for early phases of apoptosis.
In brief, cells were incubated with 0–10 mM doses of sodium iodide
for 72 h. Cells were washed twice with cold PBS, trypsinized and
resuspended in 250 μl binding buffer (10 mM HEPES/NaOH pH 7.4,
140 mM NaCl, 2.5 mM CaCl2). 0.5 μl of Annexin V-Cy5 (PharMingen,
San Diego, CA) and 10 μg propidium iodide was added to these cells
prior to detection with a LSR II cytometer (Becton Dickinson UK Ltd,
Oxford, Oxon, UK). Results were analyzedwith FlowJo Software (Flow
Cytometry Analysis Software; Tree Star, Inc., Leland Stanford, Jr.
University).
2.4. Cell cycle analysis
FRTL-5 mTSHR cells cultured in complete medium with or without
TSH and in thepresence of varyingNaI (0, 1 and10 mM)concentrations,
were plated in duplicates at a density of 3×105 cells/well in 6-well
plates. After 72 h, trypsinized cells were washed in PBS and ﬁxed in
ice-cold 70%ethanol at 4 °C for 1 h,washed, then incubated in 250 μl PBS
containing 50 μg/ml RNase for 30 min at 37 °C. Immediately prior to
ﬂow cytometry 10 μl of 1 mg/ml propidium iodide (Sigma) was added.
In each case a minimum of 10,000 events were scanned on a LSR II ﬂow
cytometer (Becton Dickinson UK Ltd., Oxford, Oxon, UK). Results were
analyzed with FlowJo Software (Flow Cytometry Analysis Software;
Tree Star, Inc., Leland Stanford, Jr. University).
2.5. RNA extraction and quantitative real-time PCR
RNA extraction and cDNA synthesis were carried out as described
and expression of the housekeeping gene S6 was measured as a
control in all samples by RT-PCR [9,10]. Real-time PCR (LightCycler
system, LightCycler-DNA MasterSYBRGreen I kit; Roche, Mannheim,
Germany) was performed using intron-spanning primers for slc5a5
(Nis), Tpo, Thrsp, Pcdha, Junb, Iyd and the housekeeping gene Rps6
(rat). For each PCR, annealing temperatures andMgCl2 concentrations
were optimized to create a one peak melting curve (primer sequences
and PCR condition are available on request).
2.6. Microarray analysis
Before microarray analysis, RNA integrity and concentration was
examined on an Agilent 2100 Bioanalyzer (Agilent Technologies, PaloAlto, CA, USA) using the RNA 6.000 LabChip Kit (Agilent Technologies)
according to the manufacturer's instructions. Microarray analysis was
conducted at the microarray core facility of the Interdisziplinäres
Zentrum für klinische Forschung (IZKF) Leipzig (Faculty of Medicine,
University of Leipzig). 3 μg of total RNA were used to prepare double-
stranded cDNA (Superscript II, Life Technologies, Gaithersburg, MD
USA) primedwith oligo-dT containing an T7 RNA polymerase promoter
site (Genset SA, Paris, France). cDNAwas puriﬁed byphenol-chloroform
extraction before in vitro transcription using the IVT labeling kit
(Affymetrix, Santa Clara, CA, USA) to synthesize cRNA. The cRNA was
fragmented and hybridized to Affymetrix Rat Genome, 230 2.0 arrays
(Affymetrix, Santa Clara, CA, USA). Washing and staining of the probe
arraywere performed according to themanufacturer's instructions. The
arraywas scannedwith a third generation affymetrix GeneChipScanner
3000.
Affymetrix GeneChip data representing approximately 30,000
transcripts with complete Rat Genome coveragewere extracted from
ﬂuorescence intensities and were scaled in order to normalize data
for inter-array comparison using MAS 5.0 software according to the
instruction of the manufacturer (Affymetrix). Our GeneChip data are
submitted to the Gene expression omnibus and to track under the
accession number GSE22118 (http://www.ncbi.nlm.nih.gov/geo/).
Microarray experiments were conducted in duplicate. Data was
ﬁltered to remove genes with a lower than 2-fold change between
experimental conditions. Genes were functionally categorized using
NetAffx (Affymetrix; http://www.affymetrix.com), KEGG (http://
david.abcc.ncifcrf.gov/), DAVID2008 (http://david.abcc.ncifcrf.gov/)
and GenMapp (http://www.genmapp.org).
3. Results
3.1. Effect of iodide on proliferation in normal and autonomous
FRTL-5 cells
The effect of 1 up to 50 mM iodide on proliferation of FRTL-5 cells
stably expressing theWT TSHR, themutant TSHR L629F or A623I were
analyzed by cell counting in the presence and absence of TSH.
In Fig. 1A TSH-independent growth is shown for clones expres-
sing the constitutively active TSHR mutations L629F and A623I. In
absence of TSH, the highest cell numbers were found for A623I
FRTL-5 cells. Similar to the previous study [11] the L629F FRTL-5 cells
showed only a moderate increase in cell number. When cells were
grown in the presence of TSH, similar increases in cell numbers were
observed for all three FRTL-5 clones (WT TSHR, L629F and A623I
mutant TSHR).
Addition of iodide inhibited proliferation in WT TSHR, L629F and
A623I FRTL-5 cells irrespective of the presence or absence of TSH
(Fig. 1B). Inhibition of proliferation was more pronounced in mutant
TSHR cells compared to WT TSHR cells and increased with long-term
iodide exposure (N72 h). Relative growth inhibition after treatment
with 1 mM NaI reached 43%, 58%, and 88% in WT TSHR, L629F mTSHR
and A623I mutant TSHR FRTL-5 cells, respectively (Fig. 1A).
3.2. Effect of iodide on apoptosis and necrosis in normal and autonomous
FRTL-5 cells
To examine whether iodide mediated growth inhibition is due to
apoptosis ornecrosisﬂowcytoﬂuorometric analysis ofAnnexinV-Cy5and
propidium iodide (PI) staining was performed after 72 h of iodide
incubation in FRTL-5 cells over-expressing the L629F mTSHR or the WT
TSHR (Fig. 2). Increased Annexin V labeling (= indicator of early
apoptosis) was observed with increased iodide doses in WT and mutant
TSHRFRTL-5 cells. Furthermore, increased iodide exposurewasassociated
with increased Annexin V and PI (= indicator of late apoptosis) labeling
indices, without differences for WT and mutant TSHR expressing FRTL-5
cells. In contrast, PI labeling indices (= indicator of necrosis) increased in
Fig. 1. Effects of iodide on cell proliferation inWT TSHR andmutant TSHR FRTL-5 cells (L629F and A623I mTSHR). Cell numbers were counted at day 3, 6, 8 and 10 after plating 5⁎104
cells/well in 12-well plates in the presence or absence of TSH (control, black square). Iodide was added in 1 mM (black upward triangle), 10 mM (black downward triangle) and
50 mM (black rhombus) concentrations. To assess for tonicity effects sodium chloride was added in the highest iodide concentration (50 mMNaCl; black circle). (A) Dose dependent
inhibition of iodide on cell growth. Three independent experiments were performed in duplicates. (B) Representative changes in cell numbers andmorphology after 96 h stimulation
with iodide in the presence of TSH in WT TSHR and L629F TSHR FRTL-5 cells (as assigned in (A) with *). NaCl in a concentration of 10 mM has no signiﬁcant effect on proliferation
unlike 50 mM NaCl (hematoxylin dye).
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found for L629F TSHR cells. This effect, however, was not signiﬁcant.
These ﬁndings suggest that the lack of growth stimulation may be
due to an increase of apoptosis in the presence of iodide.
3.3. Effect of iodide on cell cycle regulation in normal and autonomous
FRTL-5 cells
To further assess, whether the lack of growth stimulation in cells
stably expressing L629F orWT TSHR is associated with changes in cell
cycle progression, cells were analyzed by ﬂow cytometry after iodide
exposure for 72 h. As shown in Fig. 3 iodide exposure results in a shift
from G0/G1 to G2 phase in WT TSHR and L629F mTSHR FRTL-5 cells,
which is less pronounced in L629F FRTL-5 cells and is accompanied by
a S-phase reduction in these cells as previously shown by Al-Khafaji et
al. [3]. This ﬁnding is in line with the known inhibitory effects of
iodide on thyroid cell proliferation by causing G0/G1 and G2M arrest
in high concentrations [22].
3.4. Effect of iodide on global gene expression in normal and autonomous
FRTL-5 cells
To assess a broader spectrum of iodide effects on cell physiology,
transcriptome proﬁles were obtained in the L629F and the WT TSHR
FRTL-5 cell clones in the presence and absence of iodide, usingmicroarray technology. Fig. 4 summarizes the number of genes and
gene groups with at least 2-fold changes in the expression for iodide
treated (1 mM NaI) vs. control (1 mM NaCl) WT TSHR and L629F
mTSHR FRTL-5 cell clones.
To validate our GeneChip data we studied 6 iodine-regulated
genes using quantitative real-time PCR (qPCR).With themain focus of
genes involved in thyroid differentiation, we analyzed the thyroid
peroxidase (Tpo), the thyroid hormone responsive element (Thrsp),
the iodotyrosine deiodinase (Iyd) and the sodium-iodide symporter
(Slc5a5/Nis). Differential regulation of the proto-oncogene jun B
(Junb) was analyzed to validate a potential candidate with a focus on
cell proliferation. In addition, Pcdha4 (protocadherin alpha 4) a
member of the strongly regulated cadherin gene set was included in
the qPCR validation. As shown in Fig. 5 quantitative real-time PCR
analysis conﬁrmed the reduction in mRNA expression in response to
iodide in all investigated genes.
Using a cut-off of at least 2-fold expression difference our
experiments showed iodide dependent upregulation of 6 genes
(glucagon (Gcg), amphiregulin (Areg), ethanolamine kinase 1 (Etnk1),
proline–serine–threonine phosphatase-interacting protein 1 (Pstpip1)
and nuclear receptor interacting protein 3 (Nrip3) and downregulation
of 68 genes (Table 3 — online supplement) in WT TSHR and L629F
FRTL-5 cells.
Furthermore, comparison of gene expression pattern between
L629F FRTL-5 cells and WT TSHR FRTL-5 cells in the presence of
Fig. 2.Determination of apoptosis and necrosis using a ﬂow cytometry based Annexin V assay. Cells treated with 1 mM, 10 mMNaI/ NaCl for 72 h, were stained with an anti-Annexin
V antibody conjugated with Cy5 (ordinate). Propidium iodide (abscissa) was added before sorting. (A) Intact cells are located in the lower left quadrant, necrotic cells permeable to
propidium iodide are shown in the lower right quadrant, apoptotic cells stained by Annexin V and propidium iodide are located in the upper right and left quadrant. (B) Iodine
signiﬁcantly upregulated apoptosis in WT TSHR and L629F mTSHR FRTL-5 cells. (C) Induction of iodine late apoptosis as demonstrated by Annexin V and propidium iodide labeling.
(D) No signiﬁcant induction of necrosis was seen by iodide exposure. Two different experiments were performed in triplicates.
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respectively, between autonomous and normal thyroid cells (Table 3 —
online supplement). Prominently upregulated genes in L629F cell clones
were e.g. Rho GTPase activating protein 21 (Arhgap21), phosphatidyli-
nositol-4-phosphate 5-kinase type 1 alpha (Pip5k1a), collagen type XII
alpha 1 (Col12a1), ring ﬁnger protein 165 (Mf165) and neurotrophicFig. 3. Impactof iodideoncell cycle. L629FmTSHRandWTTSHRFRTL-5cellswere stimulated
with 1 mM, 10mMNaI or 10 mMNaCl in the presence of TSH for 72 h (data of 1 mMNaI and
10mM NaCl are not shown). Subsequently, cells were stained with propidium iodide and
were analyzed by ﬂow cytometry. In both normal and autonomous thyroid cells iodine
exposure induced a shift from G0/G1 to G2 phase without signiﬁcant differences for 1 or
10 mMNaI. Values are the mean±SD of two different experiments performed in triplicates.tyrosine kinase, receptor, type 3 (Ntrk3) (Fig. 4A). Differentially down-
regulated genes in L629F cell clones were e.g. iodotyrosine deiodinase
(Iyd), proto-oncogene jun B (JunB), tropomodulin 1 (Tmod1) and parvin
alpha (Parva) (Table 3 — online supplement).
Whenﬁlteringgeneswithat least 1.5-foldexpressiondifferenceusing
the DAVID2008 platform, the highest enrichment scores were obtained
for categories of genes involved in cadherin signaling, cell adhesion, and
ion binding (Table 1). Furthermore, analysis of microarray data by
principal component analysis (PCA) showed a clear separation of the
identiﬁed gene groups in WT vs. L629F TSHR FRTL-5 cells. Fig. 3B
illustrates the PCA results comprising 74.6% of the identiﬁed genes with
differential gene expression. The x-axis shows 36.8% difference in gene
expression comparingWTandL629FFRTL-5 cells,while the y-axis shows
22.3% difference in iodide-induced gene expression. This illustrates, that
the endogenous gene expression differences between autonomous
thyrocytes (harboring the L629F TSHRmutation) and normal thyrocytes
are more pronounced than effects of iodine on gene regulation. In other
words, normal thyrocytes and autonomous thyroid cells are distinct
molecular entities, with autonomy showing more impact on gene
expression than iodine treatment. Iodine exposure affects both entities
similarly but not identically. This ﬁnding is also illustrated by the total
number of individually regulated genes (698 in WT clone versus 438 in
L629F clone) and a total of only 74 genes, which are consistently
regulated in normal and autonomous thyrocytes in response to iodide.
3.5. Effects of iodide on cell function in normal and autonomous FRTL-5 cells
Since iodide is known to inhibit thyroid function, besides
proliferation, we were interested to investigate, whether this effect
Fig. 4. Analysis of GeneChip data of L629F mTSHR and WT TSHR FRTL-5 cells in the presence and absence of 1 mM NaI. (A) Summary of upregulated genes (black bars) and
downregulated genes (white bars) with at least 2-fold expression difference. Some genes are concurrently regulated inWT and L629F FRTL-5 cells. (B) 3-D visualization of a principal
component analysis of the microarray data using Partek Genomics Suite software (Partek, St. Louis, MO, USA). (C) GeneChip data of thyroid differentiation genes. Fluorescence
intensity of scan data of Tpo, Nis, Tshr and Tg in FRTL-5 hTSHR WT TSHR and L629F mTSHR FRTL-5 cells (control, black and bright shaded bars) and after 72 h 1 mM NaI treatment
(white and dark shaded bars). Columns in the graph represent mean and SD values of two GeneChips per condition (WT/ L629F mutant). RNA extraction and array hybridization
were performed in two different experiments.
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react differently compared to normal thyrocytes.
Analysis of the sodium-iodide symporter and the thyroid peroxidase
mRNA expression in WT TSHR FRTL-5 cells showed 1.5-fold down-
regulation (1.6-fold in 10 mM) and 3-fold downregulation (3.4-fold in
10 mM) in the presence of 1 mM iodide, respectively. In L629F TSHR
FRTL-5 cells, incubation with 1 mM iodide resulted in 1.8-fold down-
regulation ofNismRNA(2-fold in 10 mM) and in 3-fold downregulation
of Tpo mRNA (3.5-fold in 10 mM) (Fig. 5B). Moreover, GeneChip
analysis showed mRNA downregulation of other marker genes of
thyroid function such as Tg and Tshr in WT and mutant TSHR FRTL-5
cells upon iodide exposure (Fig. 5C). Thus, iodide causes down-
regulation of thyroid function genes without signiﬁcant difference
between normal and autonomously functioning thyroid cells.4. Discussion
Iodide is a pivotal factor in thyroid physiology and disturbed iodine
homeostasis is an important trigger of thyroid pathophysiology. In this
studywe investigate an in vitromodelof thyroidautonomytodetermine
the molecular effects of iodide on function, cell proliferation and global
gene expression pattern in early stage autonomy.
We found reduced expression of genes important for thyroid
function (Tpo, Nis, Thrsp, Iyd) in response to iodide exposure in normal
and autonomously functioning FRTL-5 cell clones. Downregulation of
functional genes has been reported in a recent SAGE analysis of the rat
PCCl-3 cell line using similar iodide concentrations [16] and is in linewith the Wolff–Chaikoff effect i.e. the inhibition of thyroid hormone
synthesis and metabolism by iodide exposure [5,8].
Furthermore, in our experiments we observed an inhibition of cell
proliferation in mutant and WT TSHR FRTL-5 cells clones, which was
more pronounced in clones with constitutive TSHR activation and in
the absence of TSH (i.e. the clinical equivalent of subclinical or overt
hyperthyroidism). This effect has been reported in a previous study by
Al-Kafahji et al. [3], but has now been demonstrated at much lower
(1 mM) iodide concentrations. Further investigations showed that the
reduction in growth is most likely due to increased apoptosis and G0/
G1 and G2M arrest [22,23] with only marginal differences for WT
TSHR andmutant TSHR cells. This could be due to the presence of TSH,
which is a strong proliferation signal for thyrocytes. However, since
the aim of our study was to assess the effect of iodide under
physiological conditions we refrained from TSH deprivation of the
investigated FRTL-5 cell clones.
Thus our in vitro data, which typify an artiﬁcial model however,
suggest that iodide slows down growth and function in normal
thyrocytes and early stage thyroid autonomy alike and may thus
provide one explanationwhy thyroid autonomy is very rare in countries
with iodide excess, e.g. Japan, despite the common molecular cause of
activating TSHR mutations [13,19].
Toget an insight into signaling events,whichare alteredby iodide,we
performed global gene expression analysis usingmicroarray technology.
Upon iodide exposure we found that a number of genes were
simultaneously upregulated in WT TSHR and L629F mutant TSHR
FRTL-5 cells. For example, upregulated genes included genes involved
in cell cycle control (amphiregulin, Areg), cell metabolism (glucagon,
Fig. 5. Downregulation of thyroid function after iodide exposure and validation of
expression difference by microarray analysis. (A) Quantitative Real-time PCR
conﬁrmation of GeneChip data. Iodide induced downregulation of thrsp, pcdha4, nis,
tpo, iyd and junb was conﬁrmed in WT TSHR and L629F TSHR FRTL-5 cells after 72 h
treatment with 1 mMNaI. Data are presented as ratio of target mRNA normalized to the
housekeeping gene ribosomal protein S6 and fold-change calculations to untreated
control cells. (B) qPCR shows dose-dependent iodide-induced inhibition of nis and tpo
mRNA expression inWT TSHR and L629Fmutant TSHR FRTL-5 cells. Data are presented as
fold-change ofnis or tpomRNAnormalized to thehousekeeping gene ribosomal protein S6
and untreated control cells. For all experiments cells were grown in the presence of TSH.
Theexperimentswereperformed three times induplicates.*Pb0.05; **Pb0.01; ***Pb0.001
(ANOVA followed by Bonferroni's post hoc test and the Students t-test).
Table 1
GeneChip data analysis using the DAVID2008 platform. Shown are the gene counts of
the ﬁrst annotation cluster with the highest enrichment score. Detailed information on
differential gene expression inWT TSHR and L629FmTSHR FRTL-5 cells and inﬂuence of
iodide on gene expression are available as a supplemental info (online Acc number
GSE22118).
Gene group Gene counts P value
Cadherin, N-terminal 13 2,60E-23
Cadherin 13 4,20E-17
Cadherin repeats 13 3,50E-16
Homophillic cell adhesion 14 2,90E-15
Cell adhesion 15 2,90E-13
Cell–cell adhesion 15 9,70E-13
Biological adhesion 18 6,80E-11
Cell adhesion 18 6,80E-11
Calcium ion binding 17 2,20E-08
Calcium 15 4,70E-08
Cation binding 24 8,50E-05
Metal ion binding 24 1,90E-04
Ion binding 24 2,80E-04
Receptor 14 6,10E-03
Transmembrane 20 3,60E-02
Membrane 23 4,50E-02
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threonine phosphatase-interacting protein 1, Pstpip1).
In contrast, the complete gene cluster of protocadherin alpha was
downregulated by iodide. We detected at least 13 highly similar coding
sequences (Pcdha1-13) and two more distantly related coding
sequences designated Pcdha c1 and Pcdha c2 in the Pcdha gene cluster,
encoding N-terminal cadherin-like extracellular and transmembrane
domains [26]. Those surface proteins are important in cell–cell adhesion
[21]. A downregulation of this gene cluster could inhibit the cell–cell-
and cell–surface adhesion and could reduce proliferation rate during
iodide treatment.
In addition, downregulation of other genes involved in cell
adhesion (laminin beta 3, Lamb3), cell metabolism (thyroid hormone
responsive protein, Thrsp) and oxidative stress response (peroxidasin,
Pxdn) underscore that iodide hampers cell viability in FRTL-5 cells.
Interestingly, more genes were found to be differential regulated
by iodide in WT TSHR FRTL-5 cells compared to L629F mTSHR FRTL-5
cells. This could be due to the endogenous constitutive activity of the
autonomous thyroid cells driving function and cell growth. However,
of the distinctly regulated mRNAs between L629F TSHR andWT TSHR
FRTL-5 cells three genes are worth highlighting due to their known
relevance to thyroid physiology: i) iodotyrosine deiodinase (Iyd), ii)
jun B proto-oncogene (Junb), and iii) the inhibitor of growth family,
member 3 (Ing3). [14].
i) The iodotyrosine deiodinase (Iyd) also known as DEHAL1,
facilitates iodide salvage in the thyroid cell thyroid by catalyzing theNADPH-dependent deiodination of mono (L-MIT) and diiodotyrosine
(L-DIT) [12]. Inactivatingmutations in the iyd gene have been identiﬁed
in rare cases of thyroid dyshormonogenesis [1,18]. Downregulation of
Iyd suggests reduced iodide salvage at the level of thyroid hormone
synthesis (in line with iodide-induced downregulation of thyroid
hormone synthesis) but hypothetically could also present an advanta-
geous escape mechanism for the autonomous cells from “inhibitory”
iodide excess.
JunbmRNA is increased by e.g. TSH and insulin and is besides c-fos
a necessary mediator and coordinator of growth response in thyroid
epithelial cells [6]. The tumor suppressor ING3 acts as a cofactor of p53
and regulates cell cycle progression, apoptosis, and DNA repair [7].
Thus downregulation of Junb and Ing3 is compatible with a more
pronounced inhibition of cell growth in autonomous L629F FRTL-5
cells compared to WT TSHR cells.
In summary, we show that distinct gene regulation occurs between
normal and autonomous thyroid cells in response to iodide and affects
genes involved in e.g. cell cycle, proliferation and metabolic processes.
Importantly, despite a constitutive TSHR activation, iodide still causes
downregulation of proliferation and function in early stage autonomy.
Future studiesneed to address this issue ina scenario closer to the in vivo
situation. Either by making use of primary cultures from toxic thyroid
nodules or an animal model of thyroid autonomy. This may open novel
perspective for the prevention of clinically relevant thyroid autonomy
through iodide treatment.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ygeno.2010.10.007.
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